Pci Biotech Holding Stock Filter Stocks by Fundamentals
| PCIB Stock | NOK 1.48 0.15 9.20% |
Fundamental analysis of PCI Biotech allows traders to better anticipate movements in PCI Biotech's stock price by examining its financial health and performance throughout various phases of its business cycle.
PCI |
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
PCI Fundamentals
| Return On Equity | -0.74 | |||
| Return On Asset | -0.4 | |||
| Operating Margin | (15.29) % | |||
| Current Valuation | 25.47 M | |||
| Shares Outstanding | 37.33 M | |||
| Shares Owned By Insiders | 31.97 % | |||
| Shares Owned By Institutions | 6.90 % | |||
| Price To Earning | (10.88) X | |||
| Price To Book | 1.44 X | |||
| Price To Sales | 18.74 X | |||
| Revenue | 6.27 M | |||
| Gross Profit | 6.27 M | |||
| EBITDA | (85.76 M) | |||
| Net Income | (88.39 M) | |||
| Cash And Equivalents | 116.12 M | |||
| Cash Per Share | 8.83 X | |||
| Total Debt | 1.28 M | |||
| Debt To Equity | 0.50 % | |||
| Current Ratio | 16.24 X | |||
| Book Value Per Share | 1.70 X | |||
| Cash Flow From Operations | (68.31 M) | |||
| Earnings Per Share | (2.35) X | |||
| Target Price | 24.0 | |||
| Number Of Employees | 14 | |||
| Beta | 1.86 | |||
| Market Capitalization | 81.93 M | |||
| Total Asset | 135.98 M | |||
| Working Capital | 38 M | |||
| Current Asset | 48 M | |||
| Current Liabilities | 10 M | |||
| Z Score | 38.4 | |||
| Net Asset | 135.98 M |
About PCI Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PCI Biotech Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PCI Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PCI Biotech Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in PCI Stock
PCI Biotech financial ratios help investors to determine whether PCI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PCI with respect to the benefits of owning PCI Biotech security.